Targeted quantitative mass spectrometric immunoassay for human protein variants

Proteome Science

Volumn 9, Issue , 2011, Pages

  Trenchevska, Olgica ^a   Nedelkov, Dobrin ^a  

^a Intrinsic Bioprobes   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYSTATIN C;

ARTICLE; HUMAN; IMMUNOASSAY; MASS SPECTROMETRY; PROTEIN MODIFICATION; PROTEIN VARIANT; PROTEOMICS; QUANTITATIVE ANALYSIS;

EID: 79953758224     PISSN: None     EISSN: 14775956     Source Type: Journal    
DOI: 10.1186/1477-5956-9-19     Document Type: Article

References (32)

1. Saudek CD, Brick JC. The clinical use of hemoglobin A1c. J Diabetes Sci Technol 2009, 3(4):629-634. 2769940, 20144304.
2. Nedelkov D. Mass spectrometry-based immunoassays for the next phase of clinical applications. Expert Rev Proteomics 2006, 3(6):631-640. 10.1586/14789450.3.6.631, 17181477.
3. Nelson RW, Krone JR, Bieber AL, Williams P. Mass-Spectrometric Immunoassay. Anal Chem 1995, 67(7):1153-1158. 10.1021/ac00103a003, 15134097.
4. Kiernan UA, Tubbs KA, Gruber K, Nedelkov D, Niederkofler EE, Williams P, Nelson RW. High-Throughput Protein Characterization Using Mass Spectrometric Immunoassay. Anal Biochem 2002, 301(1):49-56. 10.1006/abio.2001.5478, 11811966.
5. Kiernan UA, Nedelkov D, Tubbs KA, Niederkofler EE, Nelson RW. Proteomic characterization of novel serum amyloid P component variants from human plasma and urine. Proteomics 2004, 4(6):1825-1829. 10.1002/pmic.200300690, 15174148.
6. Nedelkov D, Tubbs KA, Niederkofler EE, Kiernan UA, Nelson RW. High-Throughput Comprehensive Analysis of Human Plasma Proteins: A Step toward Population Proteomics. Anal Chem 2004, 76(6):1733-1737. 10.1021/ac035105+, 15018576.
7. Jarvinen M, Rinne A, Hopsu-Havu VK. Human cystatins in normal and diseased tissues--a review. Acta Histochem 1987, 82(1):5-18.
8. Mussap M, Plebani M. Biochemistry and clinical role of human cystatin C. Crit Rev Clin Lab Sci 2004, 41(5-6):467-550. 10.1080/10408360490504934, 15603510.
9. Grubb AO. Cystatin C--properties and use as diagnostic marker. Adv Clin Chem 2000, 35:63-99. full_text, 11040958.
10. Henskens YM, Veerman EC, Nieuw Amerongen AV. Cystatins in health and disease. Biol Chem Hoppe Seyler 1996, 377(2):71-86. 10.1515/bchm3.1996.377.2.71, 8868064.
11. Reed CH. Diagnostic applications of cystatin C. Br J Biomed Sci 2000, 57(4):323-329.
12. Randers E, Erlandsen EJ. Serum cystatin C as an endogenous marker of the renal function--a review. Clin Chem Lab Med 1999, 37(4):389-395. 10.1515/CCLM.1999.064, 10369108.
13. Randers E, Kristensen JH, Erlandsen EJ, Danielsen H. Serum cystatin C as a marker of the renal function. Scand J Clin Lab Invest 1998, 58(7):585-592. 10.1080/00365519850186210, 9890342.
14. Calero M, Pawlik M, Soto C, Castano EM, Sigurdsson EM, Kumar A, Gallo G, Frangione B, Levy E. Distinct properties of wild-type and the amyloidogenic human cystatin C variant of hereditary cerebral hemorrhage with amyloidosis, Icelandic type. J Neurochem 2001, 77(2):628-637. 10.1046/j.1471-4159.2001.00256.x, 11299325.
15. Ghiso J, Jensson O, Frangione B. Amyloid fibrils in hereditary cerebral hemorrhage with amyloidosis of Icelandic type is a variant of gamma-trace basic protein (cystatin C). Proc Natl Acad Sci USA 1986, 83(9):2974-2978. 10.1073/pnas.83.9.2974, 323429, 3517880.
16. Olafsson I, Grubb A. Hereditary cystatin C amyloid angiopathy. Amyloid 2000, 7(1):70-79. 10.3109/13506120009146827, 10842708.
17. Nedelkov D, Kiernan UA, Niederkofler EE, Tubbs KA, Nelson RW. Investigating diversity in human plasma proteins. Proc Natl Acad Sci USA 2005, 102(31):10852-10857. 10.1073/pnas.0500426102, 1180507, 16043703.
18. Nedelkov D, Phillips DA, Tubbs KA, Nelson RW. Investigation of human protein variants and their frequency in the general population. Mol Cell Proteomics 2007, 6(7):1183-1187. 10.1074/mcp.M700023-MCP200, 17468123.
19. Nelson RW, Nedelkov D, Tubbs KA, Kiernan UA. Quantitative mass spectrometric immunoasay of insulin like growth factor 1. J Proteome Res 2004, 3(4):851-855. 10.1021/pr0499388, 15359740.
20. Niederkofler EE, Tubbs KA, Gruber K, Nedelkov D, Kiernan UA, Williams P, Nelson RW. Determination of beta-2 microglobulin levels in plasma using a high-throughput mass spectrometric immunoassay system. Anal Chem 2001, 73(14):3294-3299. 10.1021/ac010143j, 11476228.
21. Passing H, Bablok. A new biometrical procedure for testing the equality of measurements from two different analytical methods. Application of linear regression procedures for method comparison studies in clinical chemistry, Part I. J Clin Chem Clin Biochem 1983, 21(11):709-720.
22. Erlandsen EJ, Randers E, Kristensen JH. Reference intervals for serum cystatin C and serum creatinine in adults. Clin Chem Lab Med 1998, 36(6):393-397. 10.1515/CCLM.1998.067, 9711428.
23. Asgeirsson B, Haebel S, Thorsteinsson L, Helgason E, Gudmundsson KO, Gudmundsson G, Roepstorff P. Hereditary cystatin C amyloid angiopathy: monitoring the presence of the Leu-68-->Gln cystatin C variant in cerebrospinal fluids and monocyte cultures by MS. Biochem J 1998, 329(Pt 3):497-503. 1219069, 9445375.
24. Grubb A, Lofberg H. Human gamma-trace, a basic microprotein: amino acid sequence and presence in the adenohypophysis. Proc Natl Acad Sci USA 1982, 79(9):3024-3027. 10.1073/pnas.79.9.3024, 346341, 6283552.
25. Tang N, Tornatore P, Weinberger SR. Current developments in SELDI affinity technology. Mass Spectrom Rev 2004, 23(1):34-44. 10.1002/mas.10066, 14625891.
26. Reid JD, Holmes DT, Mason DR, Shah B, Borchers CH. Towards the development of an immuno MALDI (iMALDI) mass spectrometry assay for the diagnosis of hypertension. J Am Soc Mass Spectrom 21(10):1680-1686. 10.1016/j.jasms.2010.01.024, 20199871.
27. Kuzyk MA, Smith D, Yang J, Cross TJ, Jackson AM, Hardie DB, Anderson NL, Borchers CH. Multiple reaction monitoring-based, multiplexed, absolute quantitation of 45 proteins in human plasma. Mol Cell Proteomics 2009, 8(8):1860-1877. 10.1074/mcp.M800540-MCP200, 2722777, 19411661.
28. Anderson NL, Anderson NG, Haines LR, Hardie DB, Olafson RW, Pearson TW. Mass spectrometric quantitation of peptides and proteins using Stable Isotope Standards and Capture by Anti-Peptide Antibodies (SISCAPA). J Proteome Res 2004, 3(2):235-244. 10.1021/pr034086h, 15113099.
29. Whiteaker JR, Zhao L, Anderson L, Paulovich AG. An automated and multiplexed method for high throughput peptide immunoaffinity enrichment and multiple reaction monitoring mass spectrometry-based quantification of protein biomarkers. Mol Cell Proteomics 2010, 9(1):184-196. 10.1074/mcp.M900254-MCP200, 2808264, 19843560.
30. Addona TA, Abbatiello SE, Schilling B, Skates SJ, Mani DR, Bunk DM, Spiegelman CH, Zimmerman LJ, Ham AJ, Keshishian H, et al. Multi-site assessment of the precision and reproducibility of multiple reaction monitoring-based measurements of proteins in plasma. Nat Biotechnol 2009, 27(7):633-641. 10.1038/nbt.1546, 2855883, 19561596.
31. Aebersold R. A stress test for mass spectrometry-based proteomics. Nat Methods 2009, 6(6):411-412. 10.1038/nmeth.f.255, 19448640.
32. Bell AW, Deutsch EW, Au CE, Kearney RE, Beavis R, Sechi S, Nilsson T, Bergeron JJ. A HUPO test sample study reveals common problems in mass spectrometry-based proteomics. Nat Methods 2009, 6(6):423-430. 10.1038/nmeth.1333, 2785450, 19448641.